The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Abstract
The spontaneous nonenzymatic deamidation of glutaminyl and asparaginyl residues of peptides and proteins has been observed both in vitro and in vivo. Deamidation may change the structure and function of a peptide or protein, potentially resulting in decreased bioactivity, as well as alterations in pharmacokinetics and antigenicity of the protein pharmaceutical. Therefore, it is necessary to monitor the effect of storage and formulation conditions on deamidation of a protein drug candidate. Of particular interest is the investigation of in vivo deamidation mechanisms of protein drug candidates. Several methods are available to characterize the deamidation of peptides and proteins. We present here a LC/MS/MS method used to evaluate the deamidation of an antibody after in vivo administration. A humanized monoclonal IgG1 antibody (MAb) has several "hot spots" for spontaneous deamidation. One site, amino acid residue Asn55 located in the CDR2 region of the heavy chain, is of particular interest since deamidation at this site greatly decreases the binding activity. MAb was administered to cynomolgus monkeys by intravenous and subcutaneous routes. At various times after dosing, monkey serum was prepared and MAb captured by the immobilized antigen or a goat anti-human IgG Fcgamma antibody. The captured MAb was treated with trypsin followed by endoproteinase Glu-C. The digests were separated on RP-HPLC and analyzed by MS/MS on Q-Tof Global mass spectrometer. Using this method, we were able to determine the deamidation half-life of amino acid residue Asn55 in vivo and the ratio of the deamidated derivatives, i.e., isoAsp55 and Asp55. The method is rapid and sensitive with low-nanogram quantities of protein detected in the biological matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aswad, D. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90570-3 · Cited by 201
Distribution of glutamine and asparagine residues and their near neighbors in peptides and proteins.
Robinson, A. B., & Robinson, L. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8880 · Cited by 129
Deamidation of the asparaginyl‐glycyl sequence
Meinwald, Y. C., Stimson, E. R., & Scheraga, H. A. (1986) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1986.tb03231.x · Cited by 126
Age-dependent deamidation of asparagine residues in proteins
Lindner, H., & Helliger, W. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00140-1 · Cited by 120
Brennan, T. V., & Clarke, S. G. (1993) · Protein Science · doi:10.1002/pro.5560020305 · Cited by 117
Kosky, A. A., Razzaq, U. O., Treuheit, M. J., & Brems, D. N. (1999) · Protein Science · doi:10.1110/ps.8.11.2519 · Cited by 87
Monoclonal antibodies as therapeutics in oncology
Trikha, M., Li, Y., & Nakada, M. T. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00348-8 · Cited by 83
Monoclonal antibodies in immune and inflammatory diseases
Andreakos, E., Taylor, P. C., & Feldmann, M. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00355-5 · Cited by 53
Age-dependent deamidation of H1° histones in chromatin of mammalian tissues
Lindner, H. H., Sarg, B., Grunicke, H. H., & Helliger, W. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050261 · Cited by 47
Tsuji, K., Baczynskyj, L., & Bronson, G. E. (1992) · Analytical Chemistry · doi:10.1021/ac00041a022 · Cited by 27
Cited by
Heterogeneity of Monoclonal Antibodies
Liu, H., Gaza-Bulseco, G., Faldu, D., Chumsae, C., & Sun, J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21180 · Cited by 481
Khawli, L. A., Goswami, S., Hutchinson, R., Kwong, Z. W., Yang, J., Wang, X., Yao, Z., Sreedhara, A., Cano, T., Tesar, D. B., et al. (2010) · mAbs · doi:10.4161/mabs.2.6.13333 · Cited by 419
Advances in recombinant antibody manufacturing
Kunert, R., & Reinhart, D. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7388-9 · Cited by 417
Formulation and delivery issues for monoclonal antibody therapeutics
Daugherty, A. L., & Mrsny, R. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.011 · Cited by 351
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Metadata
- Authors
- Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M.
- Venue
- Analytical Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-01-22
- Volume
- 77
- Issue
- 5
- Pages
- 1432-1439
- ISSN
- 0003-2700 (ISSN-L)
- 1520-6882
- OpenAlex
- W1968037422
- Cited by
- 266
- References
- 10
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS. https://app.cochat.ai/papers/10.1021/ac0494174
- The paper
- Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005). In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS. Analytical Chemistry. https://doi.org/10.1021/ac0494174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.